Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study (Q42931881)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 August 2010
edit
Language Label Description Also known as
English
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
scientific article published on 19 August 2010

    Statements

    Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study (English)
    Bruno Royer
    Xavier Leleu
    Franck Bridoux
    Gilles Salles
    Veronique Leblond
    May Alakl
    19 August 2010
    4777-4782

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit